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Cryo-EM structures of lipopolysaccharide
transporter LptB2FGC in lipopolysaccharide
or AMP-PNP-bound states reveal its transport
mechanism
Xiaodi Tang1,7, Shenghai Chang2,3,7, Qinghua Luo1,7, Zhengyu Zhang4,7, Wen Qiao1, Caihuang Xu2,
Changbin Zhang1, Yang Niu1, Wenxian Yang1,5, Ting Wang1, Zhibo Zhang1, Xiaofeng Zhu1,5, Xiawei Wei1,
Changjiang Dong 6, Xing Zhang2,3 & Haohao Dong1
Lipopolysaccharides (LPS) of Gram-negative bacteria are critical for the defence against
cytotoxic substances and must be transported from the inner membrane (IM) to the outer
membrane (OM) through a bridge formed by seven membrane proteins (LptBFGCADE). The
IM component LptB2FG powers the process through a yet unclariﬁed mechanism. Here we
report three high-resolution cryo-EM structures of LptB2FG alone and complexed with LptC
(LptB2FGC), trapped in either the LPS- or AMP-PNP-bound state. The structures reveal
conformational changes between these states and substrate binding with or without LptC.
We identify two functional transmembrane arginine-containing loops interacting with the
bound AMP-PNP and elucidate allosteric communications between the domains. AMP-PNP
binding induces an inward rotation and shift of the transmembrane helices of LptFG and LptC
to tighten the cavity, with the closure of two lateral gates, to eventually expel LPS into the
bridge. Functional assays reveal the functionality of the LptF and LptG periplasmic domains.
Our ﬁndings shed light on the LPS transport mechanism.
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Antibiotic resistance of Gram-negative bacteria has becomeone of the greatest threats to global health1. The asym-metric outer membrane (OM) of Gram-negative bacteria
has a crucial role in defending against extracellular cytotoxic
molecules such as antibiotics2. Lipopolysaccharide (LPS) is the
main component of the OM, and its importance is not only in
maintaining the OM structure, shielding from harmful molecules
but also inducing host inﬂammatory immune responses causing
disease-like sepsis3–5. Compromised OM integrity reduces viru-
lence of pathogenic bacterial species and increases their sensitivity
to antimicrobial agents6.
LPS is a large glycolipid consisting of lipid A, core oligo-
saccharide and O-antigen5,7,8. Components of LPS are synthe-
sised in bacterial cytoplasm and then transported onto the
periplasmic side of the inner membrane (IM), from where mature
LPS is assembled and transported to the OM9–12. Seven LPS
transport proteins (LptBFGCADE) form a trans-envelope bridge
for LPS transport from the IM to the OM across the aqueous
periplasm13–25 (Fig. 1a), which is a potential target for novel
antimicrobial drugs26–29. The IM component LptB2FG comprises
an ATP-binding cassette (ABC) transporter, which powers the
transport of LPS across the bridge. The cytoplasmic LptB dimer
binds and hydrolyses ATP and the transmembrane (TM)
domains of LptF and LptG create a cavity to accommodate LPS
(Fig. 1a). Unlike other canonical bacterial ABC transporters,
which translocate substrate across the IM, LptB2FG acts by
extracting LPS from the periplasmic side of the IM and delivering
it to the periplasmic domain of the IM protein LptC18,30–34. LptC,
which consists of a TM helix and a jellyroll-like periplasmic
domain, forms a stable complex with LptB2FG to receive LPS
and deliver it to the periplasmic protein LptA in the bridge32,35
(Fig. 1a).
To understand the mechanisms of how LptB2FGC recognises
and acts to transport LPS, we obtained high-resolution cryo-
electron microscopy (cryo-EM) structures of LptB2FGC com-
plexed with substrate LPS or ATP analogue β-γ-imidoadenosine
5′-triphosphate (AMP-PNP). We also obtained cryo-EM struc-
ture of LptB2FG complexed with LPS to compare the con-
formational changes with and without the presence of LptC. Two
recent studies reported LptB2FGC structures: the work of Owens
et al.36 is an X-ray crystallographic study of Vibrio cholerae and
Enterobacter cloacae LptB2FGC in detergent micelles and the
work of Li et al.37 is a cryo-EM study of Escherichia coli
LptB2FGC in lipid nano-discs with and without ADP-vanadate.
Although LptB2FGC complex structures have been studied, due
to partial occupancy or low resolutions in the substrate or
nucleotide-binding pockets the two papers show no atomic evi-
dence to determine LPS recognition in LptB2FGC complex or
nucleotide-binding-induced transport mechanism36,37. By con-
trast, our high-resolution cryo-EM structures reveal atomic
details in the LPS-binding and ATP-binding cavities, and muta-
genic assays allowed us further to identify functional residues in
the TM cavity and two periplasmic domains of LptF and LptG
involved in LPS recognition and transport process including two
essential arginine residues LptF R292 and LptG R301 in the
cytoplasmic loop 2 of LptF or LptG. Conformational changes and
molecular shifts between domains upon nucleotide binding reveal
working mechanism of the transporter.
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Fig. 1 Architecture of LPS-bound sfLptB2FG complex. a A scheme of seven lipopolysaccharide transport proteins form a trans-envelope bridge to transport
LPS from the IM to the OM. b Left panel: a cross-sectional view of cryo-EM map of LPS-bound sfLptB2FG; Right panel: a closed view of LPS. A clear density
for LPS is shown in blue mesh and LPS is shown in stick. LptF, LptG and the two LptB molecules are presented in cartoon and coloured in cyan, purple, green
and yellow, respectively. c Cartoon representation of LPS-bound sfLptB2FG. An LPS molecule, shown in spheres, is located in the upper cavity of the
transmembrane channel. d Rotation of 180° along the y-axis relative to c
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Results
The ATPase activities of puriﬁed LptB2FG and LptB2FGC.
LptB2FG and LptB2FGC from Shigella ﬂexneri (sfLptB2FG and
sfLptB2FGC) were cloned, overexpressed, solubilised in n-dode-
cyl-β-D-maltopyranoside (DDM), and puriﬁed in Lauryl maltose-
neopentyl glycol (LMNG) (Supplementary Fig. 1a, b). The
ATPase activity of sfLptB2FG and sfLptB2FGC were measured
(Supplementary Fig. 1c, d). Comparing to sfLptB2FG, the ATPase
activity of sfLptB2FGC is about 50% less under the same condi-
tions, conﬁrming the reported regulatory role of LptC to
the LptB2FG transporter36,37. The ATP non-hydrolysable analo-
gue AMP-PNP signiﬁcantly inhibits the ATPase activity of
sfLptB2FGC, which was used to mimic and lock an ATP-bound
state of sfLptB2FGC.
Cryo-EM structure of LptB2FG in LPS-bound state. Our pre-
vious published crystal structure of LptB2FG from Klebsiella
pneumonia (kpLptB2FG) did not identify the bound LPS molecule
due to low resolution and low occupancy, although an extra
electron density was found in the cavity38. In this study, we used
cryo-EM to resolve an LPS-bound structure of sfLptB2FG at
overall 3.7 Å resolution with TM domain at 3.2 Å resolution
(Supplementary Figs. 2 and 3). The cryo-EM maps of sfLptB2FG
show clear side chain densities in the nucleotide-binding domains
(NBDs) and the two transmembrane domains (TMDs), allowing
us to unambiguously ﬁt models of NBDs and TMDs of LptB2FG
(Fig. 1b). LptB2 constitutes the cytoplasmic NBD dimer and the
six TM helices of LptF and LptG (F_TM1-TM6 and G_TM1-
TM6) constitute two TMDs that are arranged to form a central
cavity with two surface gaps between TM1F and TM5G and
TM1G and TM5F termed as lateral gates (Fig. 1c, d). The den-
sities for the periplasmic domains of LptF and LptG are at low
resolution but are clearly visible (Fig. 1b and Supplementary Fig.
3). Each TMD has two cytoplasmic loops: loop 1 links the TM2
and TM3 helices through the coupling helix and loop 2 links the
TM4 and TM5 helices of LptF and LptG (Fig. 1c, d).
The cryo-EM structure reveals a clear LPS density in the
central cavity (Fig. 1b), showing all six acyl tails, glucosamine
disaccharide phosphorylated at 1′ and 4′ positions, and the inner
core oligosaccharide. The LPS molecule trapped is a natural
substrate of sfLptB2FG that was overexpressed in the E. coli C43
(DE3) strain. The acyl tails of LPS are drooped and perpendicular
to the IM plane in the upper cavity and the inner core positioned
above in the periplasmic space (Fig. 1b–d). In the cavity,
hydrophobic residues I25, F26, L62, L66, L70 and M303 of LptF
and L26, I33, I66, F67, I313, F317 and Y320 of LptG interact with
the LPS acyl tails via van der Waals interactions. Charged residues
K34, K62, R133 and R136 of LptG and R33 of LptF form salt
bonds with the 1′-phosphate group of LPS, while K40 of LptG
and K317 of LptF form salt bonds with the 4′-phosphate group of
LPS. D37 of LptG interacts with the glucosamine disaccharide of
lipid A. K322, R263 and Q248 of LptF and K41 of LptG interact
with the inner core oligosaccharide (Fig. 2a, b). Previously, we
reported that mutants of the hydrophobic residues F26D and
L62D of LptF in the cavity severely impaired cell viability38. Here
we carried out functional assay amongst those conserved charged
and hydrophobic residues of LptG and found that K34E, R136E,
R133E/K136E, Y257E/Y271E and F67E/Y320E are lethal (Fig. 2c,
d and Supplementary Fig. 4). Interestingly, alanine substitution
K34A and R136A and single mutant Y257A, Y271A, F67A and
Y320A are normal (Supplementary Fig. 4). The positively charged
K34 and R136 and the hydrophobic F67 and Y320 are located in
the upper cavity in proximity to the negatively charged phosphate
group and the hydrophobic acyl chains of the bound LPS,
respectively. These results suggest that K34, R136, F67 and Y320
are important to LPS binding by forming ionic bonds and
hydrophobic interactions, respectively, which can be compen-
sated by each other if one of these interactions is lost as no effect
was seen in the single alanine mutations. However, introducing
negatively charged substitution would result repulsive force to
destabilise the ionic bond thus affecting the functionality of the
complex. On the other hand, Y257 and Y271 are located outside
the cavity at the interface between the TM and the periplasmic
domain of LptG (Fig. 2a–d and Supplementary Fig. 4). Although
not interacting with LPS, double mutant Y257E/Y271E abolishes
the functionality of the transporter causing cell death, suggesting
that their roles are not in LPS recognition but may be involved in
later stage of LPS transport to the bridge. In contrast, mutation of
residues located in the lower cavity of LptG such as K13E/R86E
showed no effect on cell viability, suggesting that the lower cavity
is not involved in LPS binding (Supplementary Fig. 4). The high
resolution within the LPS-binding cavity of the structure allowed
us to visualise that these residues interact with the trapped LPS,
supporting the results of the functional assays carried out here
and reported before39,40.
Cryo-EM structures of LptB2FGC in LPS-bound state. The
cryo-EM structure of sfLptB2FGC was determined to 3.1 Å
resolution (Fig. 3a–d and Supplementary Figs. 5 and 6). The map
shows clear densities of the TM helix of LptC located at one
lateral gate between TM1G and TM5F, which is consistent to the
published structures36,37 (Fig. 3a and Supplementary Fig. 6).
However, due to possible ﬂexibility, we are unable to see clear
density for the periplasmic domain of LptC (Fig. 3a and Sup-
plementary Fig. 6). This was also the case in the recent reported
cryo-EM structure of LptB2FGC, where most of particles collected
do not show density for the periplasmic domain of LptC37,
whereas on the other hand the reported crystal structure of
LptB2FGC was able to show clear periplasmic domains36. In our
structure, residues M1, R5, I9, L12, V16, M19 and N23 from the
TM helix of LptC interact with residues Q293, L300, L305, L304,
L307, L311 and T314 from the TM5 of LptF, respectively. In
contrast, only G21 from the TM helix of LptC interacts with V36
of TM1 of LptG (Fig. 3b). Comparing to the sfLptB2FG LPS-
bound structure, the presence of the TM helix of LptC makes the
lateral gate TM1G/TM5F of sfLptB2FGC structure much widely
opened, along with the neighbouring TM2 and TM3 of LptG and
TM4 and TM6 of LptF moved outward, resulting an enlarged
central cavity (Fig. 3e, f). In contrast to the two recent
publications36,37, a density for LPS is identiﬁed in the cavity of
sfLptB2FGC with all features visible as in the sfLptB2FG structure
except the inner core of the LPS (Fig. 3a–d). Interestingly, the LPS
molecule trapped in the cavity of sfLptB2FGC is about 7.3 Å away
from that of sfLptB2FG structure referring to the position of the
1′-phosphate group (Fig. 3e, f). The LPS molecule in the
sfLptB2FGC structure positions in proximity to LptG with kinked
acyl tails rather than drooped as seen in the sfLptB2FG structure
(Fig. 3b–d and Supplementary Fig. 6). In the cavity of
sfLptB2FGC, we can also see that hydrophobic residues L17 and
M24 from the TM helix of LptC interact with the bound LPS
(Supplementary Fig. 7), suggesting that the TM helix of LptC is
also involved in LPS recognition. The number of residues from
the TM helices of LptF and LptG that have been shown to interact
with LPS in the enlarged cavity of sfLptB2FGC are greatly reduced
compared to the structure of sfLptB2FG (Fig. 3a, b and Supple-
mentary Fig. 7). The weaker LPS binding in the cavity of
sfLptB2FGC suggests an energy regulatory role of LptC in the
transporter. The presence of LptC in the structure enlarges the
gap at one lateral gate TM1G/TM5F, which makes one to spec-
ulate that LPS may enter the cavity via this lateral gate. We can
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visualise a detergent molecule (LMNG) trapped at this lateral
gate. However, we found one acyl chain of the trapped LPS stuck
at the opposite lateral gate TM1F/TM5G (Supplementary Fig. 8),
suggesting that hydrophobic molecules to enter through these
lateral gates is also possible.
Cryo-EM structures of LptB2FGC in AMP-PNP-bound state.
To obtain a nucleotide-bound structure, we incubated the pur-
iﬁed protein sfLptB2FGC with the non-hydrolysable ATP analo-
gue AMP-PNP. Unlike the sfLptB2FGC LPS-bound structure,
LptC is moved away from the lateral gate TM1G/TM5F so that
the TM helix became invisible in the complex structure despite of
the high resolution of 3.5 Å showing near atomic details in the
cavity of the transporter (Fig. 4a–d, and Supplementary Figs. 9
and 10). Densities for the periplasmic domains of LptF and LptG
are observed at low resolution but the periplasmic domain of
LptC is unable to be visualised, which is also the case in
the recently reported ADP-vanadate complexed LptB2FGC
structure37 (Supplementary Fig. 10). Superimposition of the two
cryo-EM structures of sfLptB2FGC LPS-bound and sfLptB2FGC
AMP-PNP-bound showed two different conformations with a
root mean square deviation (RMSD) of 3.21 Å over 589 aligned
Cα atoms (Fig. 5a, b), representing two different states of the
transporter.
In our structures, the sfLptB2FG and sfLptB2FGC process an
open cavity to accommodate LPS (Fig. 5c, d), while the
sfLptB2FGC AMP-PNP-bound structure adopts a closed central
cavity with a closed dimeric conformation of LptB (Fig. 5e). The
NBDs (LptB2) of our sfLptB2FGC AMP-PNP-bound structure is
similar to that of the ATP-bound E. coli LptB dimer (PBD: 4QC2)
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with a RMSD of 0.91 Å over 457 aligned Cα atoms41, particularly
their bound nucleotides and the binding elements of LptB
match well (Supplementary Fig. 11). A superimposition of the
sfLptB2FGC AMP-PNP-bound structure and the nucleotide-free
sfLptB2FGC LPS-bound structure shows that the binding of
AMP-PNP causes an anti-clockwise rotation in the C terminal
helical domains of LptB2 towards the dimerisation interface
(Fig. 5a). The AMP-PNP binding also induces the conformational
changes of TM1–5 of LptF and TM1–5 of LptG to rotate
anti-clockwise toward the centre of the cavity (Fig. 5b), resulting
in a closed central cavity with a widely opened neck at the
periplasmic side of the cavity (Fig. 5e). No densities of LPS in this
closed cavity was observed, suggesting a post-exporting state of
LPS. Two lateral gates TM1F/TM5G and TM1G/TM5F shift into
a closed conformation with their respective TM1 and TM5 helices
oriented parallel to each other in close proximity, a ‘cis’
conformation (Supplementary Fig. 8). In this structure, a
detergent molecule (DDM) is trapped at the lateral gate TM1F/
TM5G, with hydrophobic tails trapped in the cavity while its
hydrophilic head extends into the periplasm. The hydrophobic
residues L16, I18, I21, I25 and M74 of LptF, and V309, V310,
I313, L74, L78 and M25 of LptG in the lumen of the cavity
interact with the detergent molecule (Supplementary Fig. 8).
Some of these hydrophobic residues (e.g. residues I25 of LptF,
residues L74 and I313 of LptG) are also involved in LPS binding
(Fig. 2a, b). As a result, the state of the trapped detergent
molecule in the lateral gate may suggest the way that LPS enters
the cavity of sfLptB2FGC.
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LptF R292 and LptG R301 interact with the bound AMP-PNP.
The sfLptB2FGC AMP-PNP-bound structure shows a closed
dimeric conformation of LptB with clear densities for two bound
AMP-PNP molecules in the ATP-binding sites at the interface of
the NBDs (LptB dimer) (Fig. 4a–d). Several residues are involved
in the AMP-PNP binding site, including Y13, T44, T43, Q85,
K42, E163, H195 and N38 from one LptB of the NBDs and E142,
L138 and S139 from another LptB of the NBDs (Fig. 6a, b). Some
of these residues have been tested by the functional assays in
previously published studies showing that mutations of these
residues impaired bacterial cell viability31,41. In addition to the
residues of LptB2, we also found that two arginine residues
LptF_R292 and LptG_R301 on the cytoplasmic loop 2 of LptF
and LptG extended ~9.8 and ~9.1 Å, respectively, toward the
NBDs to interact with the bound AMP-PNP molecules (Fig. 6c,
d). To test whether these arginine residues are critical for the
functionality of sfLptB2FGC, we made two single mutants LptF
R292A and LptG R301A and tested cell viability and ATPase
activity of the transporter. Interestingly these mutations showed
no impact on the ATPase activity of the complex (Supplementary
Fig. 1) but caused cell death in the functional assays (Fig. 6e, f),
suggesting that LptF R292 and LptG R301 residues are essential
for LPS transporting but not ATP hydrolysing function of the
transporter. As these loops connect TM helices that constitute the
central cavity and lateral gates, we speculate that these cyto-
plasmic R292 and R301 containing loops probably act similarly to
the coupling helices (cytoplasmic loop 1), which trigger con-
formational changes in the TMDs by allowing allosteric com-
munication between the NBDs and TMDs of LptB2FGC upon
nucleotide binding33.
Periplasmic domains of LptF and LptG may transport LPS.
Our work has showed that both LptF and LptG residues in the
cavity of the transporter sfLptB2FGC are essential and hydro-
phobic molecules like detergents can enter via both lateral gates
(Supplementary Fig. 8). We wondered whether both periplasmic
domains of LptF and LptG are crucial for the functionality of the
transporter. To test this, we generated single or double mutants
located in the core of β-jellyroll-like periplasmic domains of LptF
or LptG and performed functional assays. Mutants of conserved
residues of W204D, I163D and L206D in LptG and R212E/
Y230E, P139D/F149D, Y230E and F149D in LptF are lethal or
severely impair cell growth (Fig. 7a–f). The lethality of I163D may
be due to the lowered protein expression compared to that of the
wild type. Nevertheless, both periplasmic domains contain
functional residues that are crucial for LptB2FGC, which might
suggest that both of the periplasmic domains of LptF and LptG
are involved in LPS transport.
Discussion
The three cryo-EM structures have revealed different conforma-
tions of transporter and distinct conﬁgurations of the bound
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LPS in the presence and absence of LptC, which allowed us to
speculate the function of LptC in the transporter. In the
sfLptB2FGC LPS-bound structure, the TM helix of LptC located
between TM1G and TM5F opens up the lateral gate and enlarges
the central cavity (Fig. 3a–d). Residues from TM helices of all
LptC, LptG and LptF in the cavity make interactions with the
bound LPS suggesting all three protein components are involved
in LPS binding (Supplementary Fig. 7). However, both sfLptB2FG
and sfLptB2FGC structures trapped LPS, suggesting that extract-
ing LPS from the IM into the cavity is not determined by the
presence of LptC but LptC is present to facilitate the entry of LPS
and direct its transport toward the bridge. Deletion of the full
length LptC greatly diminishes LPS transport to LptA42, sug-
gesting its importance in bridging the IM transporter and peri-
plasmic protein LptA. Moreover, the enlarged cavity in the
sfLptB2FGC structure resulted in weaker LPS binding in the
cavity with reduced interactions between LPS and cavity residues
compared to sfLptB2FG (Fig. 2a, b and Supplementary Fig. 7),
implicating the regulatory role of LptC in making LPS transport
more energy efﬁcient. This is also supported by the reduced
ATPase activity of sfLptB2FGC compared to sfLptB2FG under the
same conditions (Supplementary Fig. 1). The TM helix of LptC
opens up the lateral gate TM1G and TM5F, makes a possible
entrance for LPS into the cavity supporting the reported
models36,37 (Supplementary Figs. 12 and 13). On the other hand,
one of the LPS acyl tails and an amphipathic detergent molecule
interact at the opposite lateral gate (TM1F/TM5G) of the struc-
tures, which may suggest that this lateral gate TM1F/TM5G could
also be accessible by LPS or amphipathic molecules in cells
(Supplementary Fig. 8).
In the sfLptB2FGC structure, LptF makes most of interactions
with LptC, and LptG only interacts with LptC through one
residue. Two recently reported structures show that the peri-
plasmic domain of LptC connects to that of LptF36,37, this makes
one to recognise the importance of LptF in LPS transport (Sup-
plementary Fig. 13). On the other hand, our mutagenic studies
reveal that the residues of LptG both in the TM cavity and
periplasmic domain show remarkable functional importance to
cell viability. Moreover, the trapped LPS molecule in the
sfLptB2FGC structure shifted 7.3 Å toward LptG compared with
the LPS in sfLptB2FG structure (Fig. 3e, f). As a result, we spec-
ulate that LptG also has important roles in LPS recognition and
transportation. Further investigations are required to clarify the
exact path of LPS transported within the transporter system.
In the sfLptB2FGC AMP-PNP-bound structure, the TM helix of
LptC moves away from the LPS-binding cavity. As a result, the TM
helices of LptF and LptG may be able to move freely to change
conformation to expel LPS out of the cavity. A comparison of the
structures shown here provides insight into the transport cycle of
sfLptB2FGC. In the nucleotide-free state, both the NBDs and TMDs
sf LptB2FGC LPS bound
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Fig. 5 Superimpositions of AMP-PNP and LPS-bound sfLptB2FGC structures. a AMP-PNP binding induces the conformational changes of LptB (NDBs). The
helical domains of the dimeric LptB (AMP-PNP-bound sfLptB2FGC) showed a rotational shift of ~12 Å in the anti-clockwise direction from the nucleotide-
free state of dimeric LptB (LPS-bound sfLptB2FGC). The LPS-bound sfLptB2FGC is coloured in the same as Fig. 1. The AMP-PNP-bound sfLptB2FGC is
coloured in marine blue and AMP-PNP shows as spheres. b A top view of superimposed transmembrane helices of LPS-bound sfLptB2FGC and AMP-PNP-
bound sfLptB2FGC complex. AMP-PNP binding induces the TM helices of AMP-PNP-bound sfLptB2FGC to rotate in the anti-clockwise direction with the
largest shift of ~10 Å from the nucleotide-free state (LPS-bound sfLptB2FGC) towards the central channel. c Slab view of surface representation of cavity of
LPS-bound sfLptB2FG. The cavity is in an outward open conformation. d Slab view of cavity of LPS-bound sfLptB2FGC. The cavity is in an outward open
conformation. The transmembrane helix of LptC is located at the lateral gate TM1G/TM5F, enlarging the cavity. The neck of the cavity is widely open.
e Slab view of cavity of AMP-PNP-bound sfLptB2FGC. The cavity is closed, which is induced by AMP-PNP binding
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are in open conformations. An LPS in the outer leaﬂet of the IM
binds laterally into the central channel of sfLptB2FG through an
open lateral gate (Figs. 1c, d and 5c and Supplementary Fig. 8). The
opening of lateral gates in this state exposes LPS-binding elements
in the lumen of the TM channel. Interactions of the hydrophobic
and charged residues of the TM helices with the six fatty acyl chains
and phosphate groups of LPS may provide sufﬁcient strength and
speciﬁcity for LPS extraction (Fig. 2a, b).
Upon nucleotides binding, two NBDs dimerise into a closed
conformation (Fig. 5a), triggering conformational changes in the
TMDs via the coupling helices and probably the cytoplasmic loop
2. The conformational changes in the NBDs induce an anti-
clockwise rotation of the TM helices of LptF and LptG towards
the centre to close the cavity (Fig. 5e and Supplementary Movies 1
and 2), like the closing motion of a camera lens aperture. The two
arginine residues (R292 of LptF and R301 of LptG) identiﬁed
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Fig. 6 R292 of LptF and R301 of LptG are involved in AMP-PNP binding. a A close view of AMP-PNP binding residues with dimeric LptB and R292 of LptF.
b A close view of AMP-PNP binding residues with dimeric LptB and R301 of LptG. AMP-PNP molecules are shown in stick, and the cryo-EM map for AMP-
PNP are shown in red mesh. c The two cryo-EM structures are superimposed. The arginine residue R292 located on the cytoplasmic loop 2 of LptF shifts
around 9.8 Å to interact with AMP-PNP. d The arginine R301 located on the cytoplasmic loop 2 of LptG shifts around 9.1 Å to interact with the AMP-PNP.
AMP-PNP molecules are shown in stick, the colour scheme of sfLptB2FGC AMP-PNP bound is the same as in Fig. 4, and sfLptB2FG LPS bound is coloured in
blue. e Functional assays of the single mutants R292 of LptF and R301 of LptG. NR1113 cells were transformed with empty vector (pTRC99a_Kan, the
negative control) or the vector encoding LptB2F(Flag)G(Myc)C (the positive control). f Detection of protein expression levels of mutants by western
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Source Data ﬁle 6f
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interacting with the bound nucleotides may have roles in
switching the states of the lateral gates of sfLptB2FGC as these
residues locate on the loop 2 that links respective TM5 of LptF
and LptG composing the lateral gates. When comparing the
‘trans’ and ‘cis’ conformations of TM1 and TM5 of the lateral
gates at the two states (Supplementary Fig. 8), it is apparent that
the gates are in closed states when the complex binds to AMP-
PNP (Fig. 5c, d).
The induced inward rotation of the TM helices results tightened
TM cavity (Fig. 5a, b), squeezing the bound LPS into the peri-
plasmic domain of LptB2FGC. The structure of the periplasmic
domains of LptF and LptG are similar to that of LptC38,39, and
the periplasmic protein LptA shares a common fold with
LptC16,18,35,43–45 and the N terminal domain of LptD21,22. Together
they form a head-to-tail oligomer with a continuous whirling
orientated hydrophobic groove bridging between the IM and the
OM25,30,46–48. The rotational motion of LptB2FGC observed in our
structures agrees with the models proposed before11,25,46 that the
rotating action from the base brings the bound LPS into the spir-
alling bridge. The design of the rotational mechanism and the need
of LptC allows efﬁcient transport of LPS through membrane bridge
powered only by LptB2FG. The non-hydrolysable nucleotide AMP-
PNP binding is able to induce conformational change suggesting
that LPS expelling does not require ATP hydrolysis. The arginine
residues on the loop 2 interact with the ﬁrst phosphate group of
AMP-PNP suggesting that the conformation of the transporter will
only return to the original ‘open’ state when the nucleotide is
released after hydrolysis.
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Fig. 7 Function of periplasmic domains of LptF and LptG. The structure of the β-jellyroll-like periplasmic domains of LptF and LptG is similar to that of LptC.
a Cartoon representation of LptF. Hydrophobic β-jellyroll-like core residues F149, P139, Y230 and R212 are shown in stick. b Functional assays of LptF
residues. Residues D129 and E265 are at the neck of the cavity as a control. Mutants R212E/Y230E, P139D/F149D, Y230E and F149D are lethal, while
mutants D129A/E265A, R212E and P139D do not have any impact on cell growth. c Protein expression level of the mutants was detected by western
blotting. Protein expression levels of other mutants are higher than that of P139D. Source data are provided as a Source Data ﬁle (7c). d Cartoon
representation of LptG. Hydrophobic β-jellyroll-like core residues I163, W204, L206 and V209 are shown in stick. e Functional assays of LptG residues.
K62 is located at the cavity as a control, and the mutant K62E grows the same as the wild type. Mutants W204D, I163D, and L206D are lethal, and mutant
V209D reduces the cell growth. f Protein expression level of mutants was detected by western blotting. Protein expression level of other mutants is higher
than that of mutant K62E except mutant I163D. The lethality of mutant I163D might cause by the lower protein expression. Source data are provided as a
Source Data ﬁle (7f)
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Our cryo-EM structures of sfLptB2FGC show similarities in the
TM domains and nucleotide-binding domains of the transporter
when superimposed with previously published cryo-EM or crystal
structures (Supplementary Fig. 13). The periplasmic domains of
LptF and LptG are however shown at different conformations,
revealing their ﬂexibility. These data suggest that the structure of
LptB2FGC is highly conserved across species, which makes it an
important protein machinery complex to study for understanding
the biosynthesis of Gram-negative bacterial membrane.
In summary, our cryo-EM structures reveal two important
intermediate states of sfLptB2FGC at high resolution, providing
molecular basis for substrate recognition and ATP induced
conformational change of LptB2FGC. The comparison of the
conformations provides a full picture of the transporting
mechanism of LptB2FGC at the NBDs and TMDs. This ﬁnding
conﬁrms rotational transporting model and explains how energy
efﬁciency is achieved by the ABC transporter in the presence
of LptC.
Methods
Expression and puriﬁcation of LptB2FGC and LptB2FG. Gene fragments con-
taining lptB and lptF-lptG of S. ﬂexneri strain were ampliﬁed separately by PCR and
subsequently cloned into a pTRC99a plasmid (EcoRI/KpnI restriction digestion for
lptB and KpnI/XbaI digestion for lptF-lptG), resulting a pTRC99a- lptB2FG con-
struct with an octa-histidine (8 × His) tag at the C terminus of LptB. Primers are
listed in Supplementary Table 2. The resulting plasmid was transformed into E. coli
C43 (DE3) cells (Novagen) for protein expression. The bacterial cells were grown in
Luria broth (LB) supplemented with antibiotic (100 µg ml−1 ampicillin) at 37 °C
until the optical density of the culture reached 0.6 at a wavelength of 600 nm
(OD600). LptB2FG expression was induced with 0.1 mM isopropyl-β-D-thioga-
lactopyranoside (IPTG) at 20 °C for 6 h. The lptC gene was ampliﬁed from S.
ﬂexneri strain and the plasmid pTRC99a- lptB2FG was linearised by PCR indivi-
dually. Subsequently, the fragments of lptC and pTRC99a-lptB2FG were ligated to
create pTRC99a-lptB2FGC. C43 (DE3) cells transformed with pTRC99a- lptB2FGC
were cultured and induced at the same conditions as described above for over-
expression of LptB2FG.
Cultures were harvested by centrifugation and cell pellets were resuspended in
puriﬁcation buffer (20 mM HEPES pH 7.8 and 300 mM NaCl) supplemented with
0.1 mM phenylmethylsulphonyl ﬂuoride (PMSF, Sigma-Aldrich). The cells were
lysed by three passes through a cell disrupter (ATS Engineering Ltd) and cell debris
was removed by centrifugation at 18,000 × g for 15 min at 4 °C. Membranes were
pelleted by ultracentrifugation at 100,000 × g for 1 h at 4 °C and solubilized in
puriﬁcation buffer supplemented with 10 mM imidazole and 1% (w/v) n-dodecyl-
β-D-maltopyranoside (DDM) (Anatrace) by stirring at room temperature for 1 h.
The suspension of solubilized protein was ultracentrifuged at 100,000 × g for 1 h
before being loaded onto a 5 ml HisTrap HP column (GE HealthCare). The
column was washed with puriﬁcation buffer supplemented with 0.05% Lauryl
Maltose Neopentyl Glycol (LMNG) and 50 mM imidazole and bound protein was
eluted with puriﬁcation buffer supplemented with 0.05% LMNG and 300 mM
imidazole. The protein eluted from Histrap HP column was further puriﬁed by
size-exclusion chromatography using a Superdex 200 Increase 10/300 column
(GE Healthcare) equilibrated in 20 mM HEPES, pH 7.8, 150 mM NaCl and 0.05%
LMNG. The purities of the protein fractions were analysed by SDS–PAGE.
Fractions with highest purity were collected and concentrated for cryo-sample
preparation. For sfLptB2FGC AMP-PNP bound, the puriﬁed sfLptB2FGC was
incubated with 5 mM β-γ-imidoadenosine 5′-phosphate (AMP-PNP) and 2 mM
MgCl2 for 1 h at room temperature before cryo-sample preparation.
ATPase activity assay. ATPase activity assay was performed using ATPase/
GTPase Activity Assay Kit (Bioassay Systems). C43 (DE3) cells carrying
sfLptB2FGC, sfLptB2FG or their mutated plasmids were cultured in 1 l LB medium.
Cells were induced, collected and lysed using the protocol described above. Solu-
bilised membrane fraction was ultracentrifuged at 100,000 × g for 30 min and the
supernatants of each sample were loaded onto a gravity column containing 2 ml
pre-balanced Ni2+-NTA beads. The columns were washed with 15 column
volumes of wash buffer (20 mM HEPES pH 7.8, 300 mM NaCl, 50 mM imidazole
and 0.05% LMNG), and eluted with the elution buffer (20 mM HEPES pH 7.8,
300 mM NaCl, 300 mM imidazole and 0.05% LMNG). All samples were further
puriﬁed using size-exclusion chromatography with a Superdex 200 Increase 10/300
column (GE Healthcare).
Protein concentration of the samples was determined using detergent compatible
Pierce BCA Protein Assay Kit (Thermo Scientiﬁc) according to the manufacture’s
instruction. Brieﬂy, 2.5 μl of puriﬁed protein was diluted to 25 μl for the BCA assay.
The albumin (BSA) was used as the standard. An aliquot of 200 μl of working
reagent (made by mixing reagent A and reagent B at 50:1 volume ratio) was added
to each sample and incubated at 37 °C for 30min. Absorbance at 562 nm was
measured and the protein concentration of each sample was determined.
The ATPase activity assays were carried out in 96-well plates. The phosphate
standards and blank control for colorimetric detection was prepared according to
the manufacturer’s instructions (ATPase/GTPase Assay Kit, Bioassay systems). An
aliquot of 1 μl (1–2 mgml−1) of samples was mixed with 4 μl detergent buffer
(20 mM HEPES, pH 7.8, 150 mM NaCl and 0.05% LMNG) and 5 μl assay buffer
(ATPase/GTPase Assay Kit) to make 10 μl ATPase activity assay sample. 30 μl
reaction solution (made by 20 μl assay buffer plus 10 μl 4 mM ATP solution) was
added into each ATPase activity assay sample and incubated at room temperature
for 15 min. The reaction was terminated by adding 200 μl reagent (ATPase/GTPase
Assay Kit) into each sample and further incubated for 30 min. The absorbance at
600 nm was measured. For AMP-PNP inhibition, sfLptB2FGC was incubated with
2 mM AMP-PNP and 5mM MgCl2 at 37 °C for 30 min before ATPase activity
assay was performed. All assays were repeated six times. ATPase activities of all
samples were determined using the mean value of the samples according to the
linear regression of standards. All experiments were repeated at least three times.
Site-directed mutagenesis and functional assays. All single or double mutations
were generated following the site-directed mutagenesis protocol published by Liu
and Naismith49. The functional assays were conducted on the E. coli lptFG chro-
mosomal deletion strain NR1113 (Courtesy to N. Ruiz.)13. lptFG deletions are
lethal, therefore NR1113 carries a rescue copy of lptFG operon with ampicillin
resistance and PBAD promotor, which is inducible by arabinose. The pTRC99a
plasmid’s ampicillin resistance gene was replaced by a kanamycin resistance gene,
which was then used as the vector for the E. coli LptB2FGC mutagenesis. In
addition to the His ×8 tag at the C terminus of LptB, we also inserted a Flag tag at
residue 138 of LptF (LptF-138-Flag) and a c-Myc tag at 144 of LptG (LptG-144-
Myc) to generate the resulting plasmid pTRC99a-E. coli LptBF138G144C-Kan.
These single or double mutants were transformed into the E. coli lptFG deletion
strain NR111313. The transformed E. coli cells were grown on LB agar plate
supplemented with antibiotics (kanamycin 50 µg ml−1) and 0.2% L-arabinose at
37 °C for 12 h. Single colonies of each transformation were inoculated into 10 ml
LB medium supplemented with the antibiotics and 0.2% (w/v) L-arabinose. The
cells were cultured in an incubator at 200 r.p.m. and at 37 °C for 12 h. Subcultured
cells were used for the functional assays. The E. coli NR1113 with the empty
plasmid pTRC99a-Kan was used as the negative control, while the NR1113 strain
with the plasmid pTRC99a-Kan-LptBF(Flag)G(Myc)C or the NR1113 strain in the
presence of 0.2% L-arabinose was used as the positive control. Cell pellets were
harvested, washed twice and diluted in sterile LB medium to the OD600 nm of 0.5.
Tenfold serial dilution functional assays were performed. The dilution range was
from 10−1 to 10−6 and 5 µl of the diluted cells was dripped onto the LB agar plates
containing kanamycin 50 μg ml−1. Cell growth was observed after overnight
culture at 37 °C. All the assays were performed in triplicate.
Western blotting. The protein expression of the LptFG mutants were determined
by western blotting. An aliquot 0.5 ml of overnight cultures of transformed NR1113
cells with LptB2FGC or mutants was inoculated into 50 ml LB supplemented with
antibiotics (kanamycin 50 µgml−1) and 0.2% L-arabinose. The cells were cultured
at 37 °C for 6 h and harvested by centrifugation. The cells were resuspended in 1 ml
buffer containing 20 mM Tris-Cl, pH 7.8 and 150 mM NaCl supplemented with
1 mM PMSF. The cells were lysed by sonication for 1 min on ice. The membrane
fraction was harvested and solubilized with 1% DDM for 20 min at room tem-
perature. The undissolved debris was removed by centrifugation at 13,000 × g for
10 min at 4 °C. The supernatant was loaded to a Ni2+-NTA column and washed
with a buffer containing 0.05% DDM, 20 mM Tris-Cl pH 7.8, 150 mM NaCl and
30 mM imidazole. The protein was eluted with 0.05% DDM, 20 mM Tris-Cl pH
7.8, 150 mM NaCl and 500 mM imidazole. The eluted samples were mixed with
4 × SDS–PAGE loading buffer and incubated at 98 °C for 10 min. The samples were
centrifuged at 13,000 × g for 1 min, and 10 μl of each sample was loaded onto 12%
Bis-Tris Plus SDS–PAGE gel for the immunoblot analysis.
The proteins were transferred to a PVDF membrane using the Mini Transfer-
Blot (Bio-Rad) at 100 V for 1 h. The PVDF membranes were blocked in 1×
phosphate buffered saline Tween-20 (PBST) supplemented with 5% skim milk at
4 °C for 1 h. The membranes were incubated with anti-Flag (Sigma, Catalogue No:
F3165) or anti-Myc monoclonal antibody (1:300 dilution) (Sigma, Catalogue No:
A5963) at room temperature for 1 h. The membranes were washed with PBST four
times and then incubated with rabbit anti-mouse IgG antibody (1:5000 dilution)
for 1 h. The membranes were washed with PBST four times and PBS twice. Protein
bands were visualised by chemiluminescent in a photo imager (Bio-Rad).
Sample preparation and cryo-EM data acquisition. 2.5 μl of puriﬁed protein
complex at a concentration of ~1 mgml−1 was applied to glow-discharged
Quantifoil holey carbon grids (R1.2/1.3, 300 mesh, copper). Grids were blotted for
3.5 s with the environmental chamber set at 95% humidity and ﬂash-frozen in
liquid ethane cooled by liquid nitrogen using Vitrobot Mark IV (FEI). Grids were
imaged with a Titan Krios (FEI) electron microscope, operated at 300 keV
equipped with a K2 Summit electron counting direct detection camera (Gatan).
Datasets were collected in super-resolution mode using the automated data
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collection programme SerialEM50. All cryo-EM images were recorded in super-
resolution mode and images were acquired at a nominal magniﬁcation of ×29,000,
corresponding to a calibrated physical pixel size of 1.014 Å. Defocus range was set
between −1.5 and −2.5 μm. Each image was acquired at an exposure time of 8 s
and dose-fractionated to 40 frames with a dose rate of about 7 counts per second
per physical pixel.
Image processing. For the cryo-EM data of sfLptB2FG LPS bound, the beam-
induced motion correction of image stacks were performed using MotionCor2 to
generate 2x binned average micrographs and dose-weighted micrographs with a
pixel size of 1.014 Å51. The contrast transfer function parameters of these average
micrographs were estimated by Gctf52. Other procedures of data processing were
performed in RELION53. 1,524,391 particles were automatically selected, and
ﬁnally 95,887 particles were selected for 3D reﬁnement and a reported 3.7 Å
resolution map was generated after post-processing with a B-factor of −107 Å2.
The data processing details are summarised in Supplementary Fig. 2.
The data processing procedures of sfLptB2FGC LPS bound were similar to the
procedures of sfLptB2FG-LPS bound. 1,928,889 particles were automatically
selected, and then two-dimensional (2D) and three-dimensional (3D)
classiﬁcations were performed to select consistent particle classes. Finally, 546,301
particles were selected for 3D reﬁnement and a reported 3.1 Å resolution map was
generated after post-processing with a B-factor of −132 Å2. The data processing
details are summarised in Supplementary Fig. 5.
The data processing procedures of sfLptB2FG AMP-PNP bound were similar to
the procedures of sfLptB2FG-LPS bound. 1,762,877 particles were automatically
selected, and then 2D and 3D classiﬁcations were performed to select consistent
particle classes. Finally, 149,178 particles were selected for 3D reﬁnement and a
reported 3.2 Å resolution map was generated after post-processing with a B-factor
of −132 Å2. The data processing details are summarised in Supplementary Fig. 9.
Model building and reﬁnement. Crystal structure of LptB2FG of K. pneumoniae
(PDB code: 5L75) was ﬁtted into the cryo-EM map of sfLptB2FG LPS bound at
3.7 Å, using UCSF Chimera54. The model was then built using COOT55. The high-
resolution cryo-EM maps allow the side chain assignments according to the bulk
side chains. There is a very clear map density in the central cavity of sfLptB2FG for
a rough LPS molecule (Supplementary Figs. 2 and 3). An LPS molecule was built in
the density using the Ra-LPS model (PDB:3FXI)56. There are densities for deter-
gents near the lateral gates, and two LMNG and four DDM molecules are built in
sfLptB2FG LPS-bound model. Although there are clear densities for the periplasmic
domains of LptF and LptG, the periplasmic domains were not able to be built due
to the low resolution. The model of sfLptB2FG-LPS bound was ﬁtted into the 3.1 Å
resolution density map of sfLptB2FGC-LPS. There are densities for LptC TM helix,
located between the lateral gate TM1G/TM5F, and LPS located in the cavity.
Contrast to the LPS trapped in the sfLptB2FG, there is no density for the core
oligosaccharide of LPS in the sfLptB2FGC complex, suggesting the core oligo-
saccharide is ﬂexible (Supplementary Fig. 6). The side chains of sfLptB2FGC
complex are assigned based on the high-resolution cryo-EM density. There is clear
density for the periplasmic domains of LptF and LptG and the two domains are
ﬁtted well in the density. The density of the periplasmic domain of LptC is not very
clear, suggesting that the periplasmic domain is ﬂexible. Detergent molecules
(DDM, LMNG) were built near the lateral gates, where LMNG molecule is trapped
in the lateral gate TM1G/TM5F (Supplementary Fig. 8). The Crystal structure of
LptB2FG of K. pneumonia (PDB code: 5L75) is ﬁtted in the density of cryo-EM
sfLptB2FGC-AMP-PNP bound map at 3.2 Å. The side chains of sfLptB2FGC-AMP-
PNP bound are assigned based on the high-resolution cryo-EM map, while there is
density for the periplasmic domains of LptF and LptG. The TM helix of LptC is no
longer at the lateral gate TM1G/TM5F and there is no clear density for LptC
periplasmic domain, suggesting that LptC is ﬂexible. The cryo-EM map of
sfLptB2FGC AMP-PNP bound has two clear densities at the active site of LptB
(Fig. 4a–d) for two AMP-PNP molecules. There is a density in the cavity through
the lateral gate TM1F/TM5G, which we identiﬁed it as a DDM molecule (Sup-
plementary Fig. 8). The three structures, sfLptB2FG LPS bound, sfLptB2FGC LPS
bound and sfLptB2FGC AMP-PNP bound, were reﬁned using the phenix.real_-
space_reﬁne in PHINEX57. Statistics of 3D reconstruction and model reﬁnement
can be found in Supplementary Table 1.
Reporting summary. Further information on research design is available in the
Nature Research Reporting Summary linked to this article.
Data availability
The atomic coordinates of sfLptB2FGC-LPS complex, sfLptB2FG-LPS complex,
sfLptB2FGC-AMP-PNP complex are deposited at Protein Data Bank under access codes
6S8N, 6S8H and 6S8G, respectively. Cryo-EM density maps of sfLptB2FGC-LPS complex,
sfLptB2FG-LPS complex, sfLptB2FGC-AMP-PNP complex are deposited at Electron
Microscopy Data Bank under access numbers EMD-10125, EMD-10122 and EMD-
10121, respectively. The source data underlying Figs. 2d, 6f, 7c and f and Supplementary
Figs. 1a–d, 4c, and 4e are provided as a Source Data ﬁle. Any other data are available
from the corresponding authors upon reasonable request.
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